387 related articles for article (PubMed ID: 28083883)
21. Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate.
Sitnik TM; Hampton JA; Henderson BW
Br J Cancer; 1998 May; 77(9):1386-94. PubMed ID: 9652753
[TBL] [Abstract][Full Text] [Related]
22. Correlation of in vivo photosensitizer fluorescence and photodynamic-therapy-induced depth of necrosis in a murine tumor model.
Cheung R; Solonenko M; Busch TM; Del Piero F; Putt ME; Hahn SM; Yodh AG
J Biomed Opt; 2003 Apr; 8(2):248-52. PubMed ID: 12683850
[TBL] [Abstract][Full Text] [Related]
23. Irradiance, Photofrin
Oakley E; Bellnier D; Hutson A; Cooper H; Habitzruther M; Sexton S; Curtin L; Tworek L; Mallory M; Henderson B; Shafirstein G
Photochem Photobiol; 2020 Mar; 96(2):397-404. PubMed ID: 31887227
[TBL] [Abstract][Full Text] [Related]
24. A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice.
Anderson CY; Freye K; Tubesing KA; Li YS; Kenney ME; Mukhtar H; Elmets CA
Photochem Photobiol; 1998 Mar; 67(3):332-6. PubMed ID: 9523532
[TBL] [Abstract][Full Text] [Related]
25. Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome.
Wang HW; Putt ME; Emanuele MJ; Shin DB; Glatstein E; Yodh AG; Busch TM
Cancer Res; 2004 Oct; 64(20):7553-61. PubMed ID: 15492282
[TBL] [Abstract][Full Text] [Related]
26. Reactive Oxygen Species Explicit Dosimetry for Photofrin-mediated Pleural Photodynamic Therapy.
Ong YH; Dimofte A; Kim MM; Finlay JC; Sheng T; Singhal S; Cengel KA; Yodh AG; Busch TM; Zhu TC
Photochem Photobiol; 2020 Mar; 96(2):340-348. PubMed ID: 31729774
[TBL] [Abstract][Full Text] [Related]
27.
Zhu TC; Kim MM; Liang X; Finlay JC; Busch TM
Photonics Lasers Med; 2015 Feb; 4(1):59-71. PubMed ID: 25927018
[TBL] [Abstract][Full Text] [Related]
28. Fluence rate as a modulator of PDT mechanisms.
Henderson BW; Busch TM; Snyder JW
Lasers Surg Med; 2006 Jun; 38(5):489-93. PubMed ID: 16615136
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Fractionated Photofrin-mediated Photodynamic Therapy Using Different Light Fluences with Reactive Oxygen Species Explicit Dosimetry (ROSED).
Sun H; Rastogi V; Zhu TC
Proc SPIE Int Soc Opt Eng; 2023; 12359():. PubMed ID: 37378071
[TBL] [Abstract][Full Text] [Related]
30.
Kim MM; Penjweini R; Zhu TC
Proc SPIE Int Soc Opt Eng; 2015 Mar; 9308():. PubMed ID: 25999655
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro.
Dysart JS; Patterson MS
Phys Med Biol; 2005 Jun; 50(11):2597-616. PubMed ID: 15901957
[TBL] [Abstract][Full Text] [Related]
32. Measurement of Cyanine Dye Photobleaching in Photosensitizer Cyanine Dye Conjugates Could Help in Optimizing Light Dosimetry for Improved Photodynamic Therapy of Cancer.
James NS; Cheruku RR; Missert JR; Sunar U; Pandey RK
Molecules; 2018 Jul; 23(8):. PubMed ID: 30042350
[TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy using intra-articular Photofrin for murine MRSA arthritis: biphasic light dose response for neutrophil-mediated antibacterial effect.
Tanaka M; Kinoshita M; Yoshihara Y; Shinomiya N; Seki S; Nemoto K; Hamblin MR; Morimoto Y
Lasers Surg Med; 2011 Mar; 43(3):221-9. PubMed ID: 21412806
[TBL] [Abstract][Full Text] [Related]
34. Photofrin photodynamic therapy: 2.0 mg/kg or not 2.0 mg/kg that is the question.
Allison RR; Sibata CH
Photodiagnosis Photodyn Ther; 2008 Jun; 5(2):112-9. PubMed ID: 19356641
[TBL] [Abstract][Full Text] [Related]
35. Oxygen limitation of direct tumor cell kill during photodynamic treatment of a murine tumor model.
Henderson BW; Fingar VH
Photochem Photobiol; 1989 Mar; 49(3):299-304. PubMed ID: 2525260
[TBL] [Abstract][Full Text] [Related]
36. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
37. PDT dose dosimetry for Photofrin-mediated pleural photodynamic therapy (pPDT).
Ong YH; Kim MM; Finlay JC; Dimofte A; Singhal S; Glatstein E; Cengel KA; Zhu TC
Phys Med Biol; 2017 Dec; 63(1):015031. PubMed ID: 29106380
[TBL] [Abstract][Full Text] [Related]
38. Effect of drug-light interval on the mode of action of Photofrin photodynamic therapy in a mouse tumor model.
Li LB; Luo RC
Lasers Med Sci; 2009 Jul; 24(4):597-603. PubMed ID: 18936869
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy for malignant mesothelioma: preclinical studies for optimization of treatment protocols.
Schouwink H; Ruevekamp M; Oppelaar H; van Veen R; Baas P; Stewart FA
Photochem Photobiol; 2001 Apr; 73(4):410-7. PubMed ID: 11332037
[TBL] [Abstract][Full Text] [Related]
40. Clinical PDT dose dosimetry for pleural Photofrin-mediated photodynamic therapy.
Sun H; Ong Y; Yang W; Sourvanos D; Dimofte A; Busch TM; Singhal S; Cengel KA; Zhu TC
J Biomed Opt; 2024 Jan; 29(1):018001. PubMed ID: 38223299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
